Guiyang Xintian Pharmaceutical Co.,Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 249.22 million compared to CNY 214.66 million a year ago. Revenue was CNY 249.22 million compared to CNY 214.66 million a year ago.

Net income was CNY 30.88 million compared to CNY 25.37 million a year ago. Basic earnings per share from continuing operations was CNY 0.1334 compared to CNY 0.113 a year ago. Diluted earnings per share from continuing operations was CNY 0.1252 compared to CNY 0.1076 a year ago.